Filing Details
- Accession Number:
- 0001209191-18-006456
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-02-01 16:15:06
- Reporting Period:
- 2018-01-31
- Accepted Time:
- 2018-02-01 16:15:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1000694 | Novavax Inc | NVAX | Biological Products, (No Disgnostic Substances) (2836) | 222816046 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1342823 | M Gregory Glenn | C/O Novavax, Inc. 20 Firstfield Road Gaithersburg MD 20878 | President, R&D | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-01-31 | 12,784 | $0.88 | 27,211 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Includes 12,784 shares acquired under the Issuer's Amended and Restated 2013 Employee Stock Purchase Plan on January 31, 2018.
Billionaire Hedge Funds
